Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine

R Baxter, J Hansen, J Timbol, V Pool… - Human Vaccines & …, 2016 - Taylor & Francis
An observational post-licensure (Phase IV) retrospective large-database safety study was
conducted at Kaiser Permanente, a US integrated medical care organization, to assess the …

Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in …

NP Klein, J Hansen, E Lewis, L Lyon… - The Pediatric …, 2010 - journals.lww.com
Background: Prelicensure clinical studies may not include sufficient numbers of subjects to
assess the potential for rare postvaccination adverse events. The aim of this postlicensure …

US Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005–2007

S Chang, PM O'Connor, BA Slade, EJ Woo - Vaccine, 2013 - Elsevier
BACKGROUND: Pre-licensure clinical trials for two US licensed tetanus toxoid, reduced
diphtheria toxoid and acellular pertussis (Tdap) vaccines did not reveal any major safety …

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents

ML Jackson, O Yu, JC Nelson… - … and drug safety, 2018 - Wiley Online Library
In light of waning immunity to pertussis following receipt of tetanus toxoid, reduced
diphtheria toxoid and acellular pertussis (Tdap) vaccine, maintaining protection may require …

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age

M Blatter, LR Friedland, WM Weston, P Li, B Howe - Vaccine, 2009 - Elsevier
PURPOSE: This study was conducted to assess the immunogenicity and safety of a tetanus
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …

Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed …

SA Halperin, S McNeil, J Langley, M Blatter, M Dionne… - Vaccine, 2011 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …

[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …

FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …

[HTML][HTML] Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on …

KR Broder, KH Brown - MMWR. Morbidity and mortality weekly report, 2011 - stacks.cdc.gov
Despite sustained high coverage for childhood pertussis vaccination, pertussis remains
poorly controlled in the United States. A total of 16,858 pertussis cases and 12 infant deaths …

Recommendation for an adolescent dose of tetanus and diphtheria toxoids and acellular pertussis vaccine: Reassurance for the future

SA Halperin - The Journal of pediatrics, 2006 - jpeds.com
Practices (ACIP) of the Centers for Disease Control and Prevention and the Committee on
Infectious Diseases of the American Academy of Pediatrics recently recommended 3 that all …

Safety surveillance of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines

PL Moro, S Perez-Vilar, P Lewis… - …, 2018 - publications.aap.org
OBJECTIVE: To assess the safety of currently licensed diphtheria-tetanus-acellular pertussis
(DTaP) vaccines in the United States by using data from the Vaccine Adverse Event …